{"url_path":"/sec/aurx/8-k/2026-06-03/item-2-03","section_key":"item-2-03","section_title":"Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-03","source_url":"https://www.sec.gov/Archives/edgar/data/1091596/0001437749-26-019199-index.html","accession_number":"0001437749-26-019199","cik":"0001091596","ticker":"AURX","issuer_name":"Nuo Therapeutics, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1091596/0001437749-26-019199-index.html","primary_entity_key":"0001091596","primary_entity_name":"Nuo Therapeutics, Inc."},"word_count":45,"has_tables":true,"body_markdown":"**Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.**\n\n \n\nThe information provided in Item 1.01 of this Current Report on Form 8-K regarding the Interim Loan Agreement is incorporated by reference into this Item 2.03."}